skip to main content
Idioma:
Resultados 1 2 3 4 5 next page
Mostrar Somente
Refinado por: Base de dados/Biblioteca: ScienceDirect remover idioma: Russo remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Everolimus for angiomyolipoma associated with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis (EXIST-2): a multicentre, randomised, double-blind, placebo-controlled trial
Everolimus for angiomyolipoma associated with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis (EXIST-2): a multicentre, randomised, double-blind, placebo-controlled trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Everolimus for angiomyolipoma associated with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis (EXIST-2): a multicentre, randomised, double-blind, placebo-controlled trial

Bissler, John J, Prof ; Kingswood, J Christopher, FRCP ; Radzikowska, Elżbieta, MD ; Zonnenberg, Bernard A, MD ; Frost, Michael, MD ; Belousova, Elena, Prof ; Sauter, Matthias, MD ; Nonomura, Norio, Prof ; Brakemeier, Susanne, MD ; de Vries, Petrus J, Prof ; Whittemore, Vicky H, PhD ; Chen, David, PhD ; Sahmoud, Tarek, MD ; Shah, Gaurav, MD ; Lincy, Jeremie, MS ; Lebwohl, David, MD ; Budde, Klemens, Prof

The Lancet (British edition), 2013-03, Vol.381 (9869), p.817-824 [Periódico revisado por pares]

Kidlington: Elsevier

Texto completo disponível

Citações Citado por
2
Ramucirumab monotherapy for previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (REGARD): an international, randomised, multicentre, placebo-controlled, phase 3 trial
Ramucirumab monotherapy for previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (REGARD): an international, randomised, multicentre, placebo-controlled, phase 3 trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Ramucirumab monotherapy for previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (REGARD): an international, randomised, multicentre, placebo-controlled, phase 3 trial

Fuchs, Charles S, Dr Prof ; Tomasek, Jiri, MD ; Yong, Cho Jae, Prof ; Dumitru, Filip, MD ; Passalacqua, Rodolfo, MD ; Goswami, Chanchal, Prof ; Safran, Howard, Prof ; dos Santos, Lucas Vieira, MD ; Aprile, Giuseppe, MD ; Ferry, David R, Prof ; Melichar, Bohuslav, Prof ; Tehfe, Mustapha, MD ; Topuzov, Eldar, Prof ; Zalcberg, John Raymond, Prof ; Chau, Ian, MD ; Campbell, William, Prof ; Sivanandan, Choondal, MD ; Pikiel, Joanna, MD ; Koshiji, Minori, MD ; Hsu, Yanzhi, PhD ; Liepa, Astra M, PharmD ; Gao, Ling, PhD ; Schwartz, Jonathan D, MD ; Tabernero, Josep, MD

The Lancet (British edition), 2014-01, Vol.383 (9911), p.31-39 [Periódico revisado por pares]

Kidlington: Elsevier Ltd

Texto completo disponível

Citações Citado por
3
Autonomic Denervation Added to Pulmonary Vein Isolation for Paroxysmal Atrial Fibrillation: A Randomized Clinical Trial
Autonomic Denervation Added to Pulmonary Vein Isolation for Paroxysmal Atrial Fibrillation: A Randomized Clinical Trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Autonomic Denervation Added to Pulmonary Vein Isolation for Paroxysmal Atrial Fibrillation: A Randomized Clinical Trial

KATRITSIS, Demosthenes G ; POKUSHALOV, Evgeny ; ROMANOV, Alexander ; GIAZITZOGLOU, Eleftherios ; SIONTIS, George C. M ; PO, Sunny S ; CAMM, A. John ; IOANNIDIS, John P. A

Journal of the American College of Cardiology, 2013-12, Vol.62 (24), p.2318-2325 [Periódico revisado por pares]

New York, NY: Elsevier

Texto completo disponível

Citações Citado por
4
Simeprevir with pegylated interferon alfa 2a plus ribavirin in treatment-naive patients with chronic hepatitis C virus genotype 1 infection (QUEST-1): a phase 3, randomised, double-blind, placebo-controlled trial
Simeprevir with pegylated interferon alfa 2a plus ribavirin in treatment-naive patients with chronic hepatitis C virus genotype 1 infection (QUEST-1): a phase 3, randomised, double-blind, placebo-controlled trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Simeprevir with pegylated interferon alfa 2a plus ribavirin in treatment-naive patients with chronic hepatitis C virus genotype 1 infection (QUEST-1): a phase 3, randomised, double-blind, placebo-controlled trial

Jacobson, Ira M, Prof ; Dore, Gregory J, Prof ; Foster, Graham R, Prof ; Fried, Michael W, Prof ; Radu, Monica, MD ; Rafalsky, Vladimir V, Prof ; Moroz, Larysa, Prof ; Craxi, Antonio, Prof ; Peeters, Monika, MSc ; Lenz, Oliver, PhD ; Ouwerkerk-Mahadevan, Sivi, PhD ; De La Rosa, Guy, MD ; Kalmeijer, Ronald, MD ; Scott, Jane, PhD ; Sinha, Rekha, PhD ; Beumont-Mauviel, Maria, PhD

The Lancet (British edition), 2014-08, Vol.384 (9941), p.403-413 [Periódico revisado por pares]

Kidlington: Elsevier Ltd

Texto completo disponível

Citações Citado por
5
Efficacy and safety of everolimus for subependymal giant cell astrocytomas associated with tuberous sclerosis complex (EXIST-1): a multicentre, randomised, placebo-controlled phase 3 trial
Efficacy and safety of everolimus for subependymal giant cell astrocytomas associated with tuberous sclerosis complex (EXIST-1): a multicentre, randomised, placebo-controlled phase 3 trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Efficacy and safety of everolimus for subependymal giant cell astrocytomas associated with tuberous sclerosis complex (EXIST-1): a multicentre, randomised, placebo-controlled phase 3 trial

Franz, David Neal, Prof ; Belousova, Elena, MD ; Sparagana, Steven, MD ; Bebin, E Martina, MD ; Frost, Michael, MD ; Kuperman, Rachel, MD ; Witt, Olaf, MD ; Kohrman, Michael H, MD ; Flamini, J Robert, MD ; Wu, Joyce Y, MD ; Curatolo, Paolo, Prof ; de Vries, Petrus J, Prof ; Whittemore, Vicky H, PhD ; Thiele, Elizabeth A, MD ; Ford, James P, MS ; Shah, Gaurav, MD ; Cauwel, Helene, MSc ; Lebwohl, David, MD ; Sahmoud, Tarek, MD ; Jozwiak, Sergiusz, MD

The Lancet (British edition), 2013-01, Vol.381 (9861), p.125-132 [Periódico revisado por pares]

Kidlington: Elsevier Ltd

Texto completo disponível

Citações Citado por
6
Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial
Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial

Navarra, Sandra V, MD ; Guzmán, Renato M, MD ; Gallacher, Alberto E, MD ; Hall, Stephen, MD ; Levy, Roger A, MD ; Jimenez, Renato E, MD ; Li, Edmund K-M, MD ; Thomas, Mathew, MD ; Kim, Ho-Youn, MD ; León, Manuel G, MD ; Tanasescu, Coman, MD ; Nasonov, Eugeny, MD ; Lan, Joung-Liang, MD ; Pineda, Lilia, MD ; Zhong, Z John, PhD ; Freimuth, William, MD ; Petri, Michelle A, MD

The Lancet (British edition), 2011, Vol.377 (9767), p.721-731 [Periódico revisado por pares]

Kidlington: Elsevier Ltd

Texto completo disponível

Citações Citado por
7
Eribulin monotherapy versus treatment of physician's choice in patients with metastatic breast cancer (EMBRACE): a phase 3 open-label randomised study
Eribulin monotherapy versus treatment of physician's choice in patients with metastatic breast cancer (EMBRACE): a phase 3 open-label randomised study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Eribulin monotherapy versus treatment of physician's choice in patients with metastatic breast cancer (EMBRACE): a phase 3 open-label randomised study

Cortes, Javier, MD ; O'Shaughnessy, Joyce, MD ; Loesch, David, MD ; Blum, Joanne L, MD ; Vahdat, Linda T, MD ; Petrakova, Katarina, MD ; Chollet, Philippe, MD ; Manikas, Alexey, MD ; Diéras, Veronique, MD ; Delozier, Thierry, MD ; Vladimirov, Vladimir, MD ; Cardoso, Fatima, MD ; Koh, Han, MD ; Bougnoux, Philippe, MD ; Dutcus, Corina E, MD ; Seegobin, Seth, MSc ; Mir, Denis, MSc ; Meneses, Nicole, MSHS ; Wanders, Jantien, MD ; Twelves, Chris, Prof

The Lancet (British edition), 2011-03, Vol.377 (9769), p.914-923 [Periódico revisado por pares]

Kidlington: Elsevier Ltd

Texto completo disponível

Citações Citado por
8
Efficacy and safety of ipilimumab monotherapy in patients with pretreated advanced melanoma: a multicenter single-arm phase II study
Efficacy and safety of ipilimumab monotherapy in patients with pretreated advanced melanoma: a multicenter single-arm phase II study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Efficacy and safety of ipilimumab monotherapy in patients with pretreated advanced melanoma: a multicenter single-arm phase II study

O'Day, S.J. ; Maio, M. ; Chiarion-Sileni, V. ; Gajewski, T.F. ; Pehamberger, H. ; Bondarenko, I.N. ; Queirolo, P. ; Lundgren, L. ; Mikhailov, S. ; Roman, L. ; Verschraegen, C. ; Humphrey, R. ; Ibrahim, R. ; de Pril, V. ; Hoos, A. ; Wolchok, J.D.

Annals of oncology, 2010-08, Vol.21 (8), p.1712-1717 [Periódico revisado por pares]

Oxford: Elsevier Ltd

Texto completo disponível

Citações Citado por
9
A Prospective, Randomised EORTC Intergroup Phase 3 Study Comparing the Oncologic Outcome of Elective Nephron-Sparing Surgery and Radical Nephrectomy for Low-Stage Renal Cell Carcinoma
A Prospective, Randomised EORTC Intergroup Phase 3 Study Comparing the Oncologic Outcome of Elective Nephron-Sparing Surgery and Radical Nephrectomy for Low-Stage Renal Cell Carcinoma
Material Type:
Artigo 		Adicionar ao Meu Espaço

A Prospective, Randomised EORTC Intergroup Phase 3 Study Comparing the Oncologic Outcome of Elective Nephron-Sparing Surgery and Radical Nephrectomy for Low-Stage Renal Cell Carcinoma

Van Poppel, Hendrik ; Da Pozzo, Luigi ; Albrecht, Walter ; Matveev, Vsevolod ; Bono, Aldo ; Borkowski, Andrzej ; Colombel, Marc ; Klotz, Laurence ; Skinner, Eila ; Keane, Thomas ; Marreaud, Sandrine ; Collette, Sandra ; Sylvester, Richard

European urology, 2011-04, Vol.59 (4), p.543-552 [Periódico revisado por pares]

Kidlington: Elsevier B.V

Texto completo disponível

Citações Citado por
10
Once-daily dolutegravir versus twice-daily raltegravir in antiretroviral-naive adults with HIV-1 infection (SPRING-2 study): 96 week results from a randomised, double-blind, non-inferiority trial
Once-daily dolutegravir versus twice-daily raltegravir in antiretroviral-naive adults with HIV-1 infection (SPRING-2 study): 96 week results from a randomised, double-blind, non-inferiority trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Once-daily dolutegravir versus twice-daily raltegravir in antiretroviral-naive adults with HIV-1 infection (SPRING-2 study): 96 week results from a randomised, double-blind, non-inferiority trial

Raffi, François, Prof ; Jaeger, Hans, MD ; Quiros-Roldan, Eugenia, MD ; Albrecht, Helmut, Prof ; Belonosova, Elena, MD ; Gatell, Jose M, Prof ; Baril, Jean-Guy, MD ; Domingo, Pere, MD ; Brennan, Clare, DPT ; Almond, Steve, MMath ; Min, Sherene, MD

The Lancet infectious diseases, 2013-11, Vol.13 (11), p.927-935 [Periódico revisado por pares]

London: Elsevier Ltd

Texto completo disponível

Citações Citado por
Resultados 1 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Mostrar Somente

  1. Revistas revisadas por pares (423)

Refinar Meus Resultados

Assunto 

  1. Female  (420)
  2. Science & Technology  (392)
  3. Life Sciences & Biomedicine  (391)
  4. Humans  (308)
  5. Male  (296)
  6. Adult  (195)
  7. Middle Aged  (179)
  8. Aged  (137)
  9. Animals  (131)
  10. Neurosciences & Neurology  (82)
  11. Adolescent  (78)
  12. Neurosciences  (72)
  13. Oncology  (58)
  14. Treatment Outcome  (58)
  15. Aged, 80 And Over  (55)
  16. Rats  (40)
  17. Young Adult  (40)
  18. Mice  (39)
  19. Pharmacology & Pharmacy  (36)
  20. Pregnancy  (33)
  21. Mais opções open sub menu

Data de Publicação 

De até
Refinar
  1. Antes de1994  (25)
  2. 1994Até1998  (49)
  3. 1999Até2003  (91)
  4. 2004Até2009  (126)
  5. Após 2009  (136)
  6. Mais opções open sub menu

Idioma 

  1. Inglês  (421)
  2. Japonês  (71)
  3. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.